#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17384	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2053	840.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	987	C	921	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32012	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3549	899.3	0	.	n	.	0	T695C	SNP	695	695	T	1036	1036	C	1023	C	932	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32012	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3549	899.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1678	1678	A	1083	A	1006	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32012	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3549	899.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2312	2312	C	1026	C,T	942,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32012	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3549	899.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2386	2386	A	1037	A	971	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32012	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3549	899.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2938	2938	C	975	C	907	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	27	2174	folP	852	852	100.0	folP.l15.c30.ctg.1	1658	130.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1095	1097	AGC	199;201;202	A;G;C	185;187;186	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5774	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3378	170.3	1	SNP	p	S91F	0	.	.	271	273	TCC	507	509	TCC	193;193;189	T;C;C	182;182;180	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5774	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3378	170.3	1	SNP	p	D95G	0	.	.	283	285	GAC	519	521	GAC	194;193;192	G;A,T;C	184;184,1;184	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5774	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3378	170.3	1	SNP	p	D95N	0	.	.	283	285	GAC	519	521	GAC	194;193;192	G;A,T;C	184;184,1;184	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1716	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1339	127.4	1	SNP	p	G45D	0	.	.	133	135	GGC	437	439	GGC	215;215;213	G;G;C	201;202;199	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	922	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1045	87.9	0	.	n	.	0	A197.	DEL	197	197	A	608	608	A	221	A	204	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5910	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2788	210.7	1	SNP	p	D86N	0	.	.	256	258	GAC	445	447	GAC	230;231;230	G,A;A;C	215,1;215;215	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5910	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2788	210.7	1	SNP	p	S88P	0	.	.	262	264	TCC	451	453	TCC	233;236;238	T;C;C	217;219;221	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4738	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2633	179.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1587	1589	GGC	208;208;206	G;G;C	194;194;189	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	4522	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2583	174.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1351	1353	GCA	246;243;242	G;C;A,T	220;216;219,1	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4522	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2583	174.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1354	1356	ATC	244;242;244	A;T;C	223;221;222	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4522	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2583	174.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1366	1368	GTG	245;243;243	G;T;G	228;221;226	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4522	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2583	174.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1366	1368	GTG	245;243;243	G;T;G	228;221;226	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4522	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2583	174.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1870	1872	ACC	219;220;223	A;C;C	210;213;215	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4522	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2583	174.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1924	1926	GCG	239;241;240	G;C;G	208;180;200	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4522	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2583	174.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1924	1926	GCG	239;241;240	G;C;G	208;180;200	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4522	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2583	174.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2047	2049	GGT	207;202;205	G;G;T	191;186;188	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4522	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2583	174.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2056	2058	GGC	208;205;205	G;G;C	186;184;186	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4522	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2583	174.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2074	2076	CCG	185;188;187	C,G;C,G;G	147,7;150,1;148	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6524	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3070	211.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1533	1535	CCG	238;243;245	C;C;G,A	213;221;219,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2416	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1711	140.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	343	345	GGC	178;175;177	G;G;C	165;163;166	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2416	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1711	140.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	525	525	C	168	C	147	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3304	porB1b	1038	1038	98.65	porB1b.l6.c4.ctg.1	1663	197.7	0	.	p	.	0	I45V	NONSYN	133	135	ATT	483	485	GTT	261;259;261	G,A;T;T	246,1;242;249	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3304	porB1b	1038	1038	98.65	porB1b.l6.c4.ctg.1	1663	197.7	0	.	p	.	0	S54A	NONSYN	160	162	TCC	510	512	GCC	262;260;260	G,T;C;C	244,1;245;245	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3304	porB1b	1038	1038	98.65	porB1b.l6.c4.ctg.1	1663	197.7	0	.	p	.	0	I75V	NONSYN	223	225	ATT	573	575	GTT	261;267;266	G;T;T	243;237;241	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3304	porB1b	1038	1038	98.65	porB1b.l6.c4.ctg.1	1663	197.7	0	.	p	.	0	S89T	NONSYN	265	267	AGC	615	617	ACC	279;277;276	A,C;C;C	242,1;247;249	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3304	porB1b	1038	1038	98.65	porB1b.l6.c4.ctg.1	1663	197.7	0	.	p	.	0	I98V	NONSYN	292	294	ATC	642	644	GTC	267;262;258	G;T;C	246;244;238	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3304	porB1b	1038	1038	98.65	porB1b.l6.c4.ctg.1	1663	197.7	0	.	p	.	0	T106I	NONSYN	316	318	ACC	666	668	ATC	254;253;250	A;T;C	233;230;225	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12418	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4914	252.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1344	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1000	133.6	1	SNP	p	V57M	1	.	.	169	171	ATG	523	525	ATG	259;260;258	A;T;G	238;241;240	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
